Axitinib price
Axitinib (Axitinib) is an oral targeted therapy drug, mainly used for the treatment of advanced renal cell carcinoma (renal cell carcinoma, RCC). The drug, developed by Pfizer Inc., has been approved for patients with certain types of renal cell carcinoma, especially those who have failed or are intolerant to other treatments.
Axitinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The price of 5mg*28 tablets is about 5,000 to 6,000 yuan. For specific prices, please consult the local hospital pharmacy. There are original and generic axitinib drugs abroad. The original drug is Pfizer's original drug, and the price is about 6,000 yuan; the generic drugs are mainly Bangladeshi generics and Indian generics. The price of Bangladeshi generics in 5mg*60 tablets is more than 1,000 yuan, and the price of Indian generics is around a few hundred yuan. The ingredients of original drugs and generic drugs are basically the same.

The therapeutic mechanism of axitinib mainly involves targeting the vascular endothelial growth factor receptor (VEGFR). VEGFRPlays an important role in regulating angiogenesis, and cancer cells usually increase angiogenesis to obtain more nutrients and oxygen supply, promoting their growth and spread. Axitinib blocks this process by inhibiting VEGFR, limiting the blood supply to tumor cells, thereby inhibiting tumor growth.
Axitinib has achieved some success in the treatment of renal cell carcinoma and has become one of the first-line treatment options. Patients usually require daily oral axitinib, and the specific dosage and treatment regimen will be adjusted based on the patient's specific condition. During treatment, patients need to receive regular monitoring and follow-up from their doctor to ensure the effectiveness of the drug and handle possible side effects in a timely manner.
Common side effects of axitinib include hypertension, hand-foot syndrome, proteinuria, etc. Patients should pay close attention to their physical condition during medication and promptly report any abnormal reactions to their doctor. Doctors may adjust the dose of the drug or take other measures based on the patient's specific condition to minimize the impact of side effects on the patient's quality of life.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)